Decoding the M&A landscape Kavita Jani Feb 5, 2025 Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…
M&A in pharma sees deals worth $14.8 bn in Nov 2024 EP News Bureau Dec 9, 2024 According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…
Biocon expands its generic formulations, launches Everolimus tablets in US EP News Bureau Oct 5, 2021 Everolimus (Afinitor) is a prescription medication that is used to treat certain types of cancers and tumours
Novartis pays $729 million to settle US kickback charges Reuters Jul 2, 2020 The Swiss drugmaker will pay $678 million to resolve claims it organized tens of thousands of sham educational events where it…
Novartis to test efficacy of old malaria drug against COVID-19 Reuters Apr 21, 2020 The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters
Eris Lifesciences acquires trademark Zomelis (for Vildagliptin) from Novartis AG for India market EP News Bureau Dec 4, 2019 Zomelis is used in the treatment of type 2 diabetes and comes under a new class of anti-diabetic drugs known as DPP 4 inhibitors